Skip to main content

IBIO

Stock
Health Care
Biotechnology

Performance overview

IBIO Price
Price Chart

Forward-looking statistics

Beta
0.65
Risk
100.00%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

iBio Inc is a part of the healthcare sector. Its main business is commercialized technologies and product candidates and manufacturing services to clients and collaborators. Its main area of business is plant-based protein expression technologies for vaccines and therapeutic proteins and developing and commercializing select biopharmaceutical product candidates. Its products are used to combat various areas such as fibrotic diseases, cancers, and infectious diseases. The company operates in two segments: Biopharmaceuticals and Bioprocessing activities, conducted within iBio, Inc. and CDMO segment, conducted within iBio CDMO.

Company info

SectorHealth Care
IndustryBiotechnology
Employees70
Market cap$20.9M

Fundamentals

Enterprise value$12.0M
Revenue$375.0K
Revenue per employee—
Profit margin0.00%
Debt to equity37.96

Security info

ExchangeNyse American
Type of shareCommon Stock
Earnings per share (EPS)-$0.04
Dividend per share—
Revenue per share$0.04
Avg trading volume (30 day)$3M
Avg trading volume (10 day)$7M
Put-call ratio—

Macro factor sensitivity

Growth+2.7
Credit-3.3
Liquidity-2.3
Inflation+4.1
Commodities+1.7
Interest Rates-2.0

Valuation

Dividend yield0.00%
PEG Ratio-0.45
Price to sales32.05
P/E Ratio-0.45
Enterprise Value to Revenue31.91
Price to book0.66

Upcoming events

Next earnings dayMay 2, 2025
Next dividend day—
Ex. dividend day—

News

Top 4 Health Care Stocks That May Rocket Higher In Q1 - AlloVir (NASDAQ:ALVR), GRI Bio (NASDAQ:GRI)

The most oversold stocks in the health care presents an opportunity to buy into undervalued companies.

Benzinga (January 16, 2024)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free